Published in Clin Immunol Immunopathol on March 01, 1976
Induction of canine autoantibody to prostatic neoantigen. Clin Exp Immunol (1978) 0.75
Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J Infect Dis (1975) 4.36
Pyoverdin is essential for virulence of Pseudomonas aeruginosa. Infect Immun (1996) 3.51
Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa. Infect Immun (1978) 3.15
Loss of virulence associated with absence of flagellum in an isogenic mutant of Pseudomonas aeruginosa in the burned-mouse model. Infect Immun (1982) 2.48
Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: extracellular protease and elastase as in vivo virulence factors. Can J Microbiol (1979) 2.30
Flagella of Salmonella typhimurium are a virulence factor in infected C57BL/6J mice. Infect Immun (1984) 2.15
Flagellar preparations from Pseudomonas aeruginosa: animal protection studies. Infect Immun (1982) 2.01
Aetiology of Kaposi's sarcoma. Lancet (1990) 1.95
Infected surface wound: an experimental model and a method for the quantitation of bacteria in infected tissues. Appl Microbiol (1972) 1.89
Experimental studies on the pathogenesis of infections due to Pseudomonas aeruginosa: direct evidence for toxin production during Pseudomonas infection of burned skin tissues. J Infect Dis (1977) 1.84
Burn wounds: microbiology, local host defenses, and current therapy. CRC Crit Rev Clin Lab Sci (1973) 1.70
Flagellar preparations from Pseudomonas aeruginosa: isolation and characterization. Infect Immun (1982) 1.67
Experience with Candida infections in the burn patient. Arch Surg (1972) 1.38
Epidemiology of Pseudomonas aeruginosa in a burns hospital: surveillance by a combined typing system. Appl Microbiol (1972) 1.27
Growth of Pseudomonas aeruginosa in normal and burned skin extract: role of extracellular proteases. Infect Immun (1979) 1.26
Tissue- and species-specific antigens of normal human prostatic tissue. J Immunol (1970) 1.22
The effect of estrogen on the incorporation of 3H-thymidine by PHA-stimulated human peripheral blood lymphocytes. J Immunol (1974) 1.21
Avirulence of a Pseudomonas aeruginosa algC mutant in a burned-mouse model of infection. Infect Immun (1995) 1.20
Control of surface wound infection: skin versus synthetic grafts. Appl Microbiol (1973) 1.19
Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations. J Urol (1970) 1.18
Epidemiology of pseudomonas aeruginosa in a burn hospital: evaluation of serological, bacteriophage, and pyocin typing methods. Appl Microbiol (1972) 1.17
Effect of Antibiotic and Chemical Dips on the Microflora of Packaged Salad Mix. Appl Microbiol (1960) 1.17
The pathogenesis of infections owing to Pseudomonas aeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, Cincinnati. Can J Microbiol (1985) 1.12
Experimental studies of the pathogenesis of infections owing to Pseudomonas aeruginosa: elastase, an IgG protease. Can J Microbiol (1984) 1.10
Thymus-specific antigens on human thymocytes and on thymic-derived lymphocytes. Transplantation (1973) 1.10
IgE in pemphigus. Arch Dermatol (1977) 1.09
Immunologic studies of normal, benign, and malignant human prostatic tissue. Cancer (1972) 1.09
Secreted products of a nonmucoid Pseudomonas aeruginosa strain induce two modes of macrophage killing: external-ATP-dependent, P2Z-receptor-mediated necrosis and ATP-independent, caspase-mediated apoptosis. Microbiology (2000) 1.07
Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations. J Trauma (1986) 1.07
Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes. Infect Immun (1986) 1.05
Precipitating antigens of the normal human prostate. J Reprod Fertil (1970) 1.04
Enhanced survival in burned mice treated with antiserum prepared against normal and burned skin. J Trauma (1971) 1.03
Modifications of a Candida albicans biotyping system. J Clin Microbiol (1989) 1.02
Pemphigus-like antibodies in patients with skin burns. Vox Sang (1969) 1.02
Cytotoxicity testing of topical antimicrobial agents on human keratinocytes and fibroblasts for cultured skin grafts. J Burn Care Rehabil (1995) 1.01
Precipitating antibody in the sera of patients treated cryosurgically for carcinoma of the prostate. Exp Med Surg (1969) 0.98
Effect of a synthetic dressing formed on a burn wound in rats: a comparison of allografts, collagen sheets, and polyhydroxyethylmethacrylate in the control of wound infection. Appl Microbiol (1974) 0.98
Serum proteins in patients with benign and malignant diseases of the prostate. Neoplasma (1971) 0.97
Blood product immunosuppression and the acquired immunodeficiency syndrome. Ann Intern Med (1986) 0.97
Effect of proteolytic activity on virulence of Candida albicans in burned mice. Infect Immun (1990) 0.96
Evaluation of candida precipitin and agglutinin tests for the diagnosis of systemic candidiasis in burn patients. J Clin Microbiol (1977) 0.95
Noncytotoxic combinations of topical antimicrobial agents for use with cultured skin substitutes. Antimicrob Agents Chemother (1995) 0.94
Speciation and amphotericin B sensitivity studies on blood isolates of Candida from burned patients. J Clin Pathol (1973) 0.93
Experimental studies of the pathogenesis of Pseudomonas aeruginosa infection: evidence for the in-vivo production of a lethal toxin. J Med Microbiol (1978) 0.91
Alterations of alpha2-globulin and the clinical response in patients with prostatic cancer following cryotherapy. Oncology (1975) 0.91
Localization of immunoglobulins in human prostatic tissue. J Immunol (1971) 0.90
Tissue- and species-specific antibodies in antithymocyte globulin. Transplantation (1972) 0.90
Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate. Cancer Res (1978) 0.89
Hormonal therapy and alteration of lymphocyte proliferation. J Lab Clin Med (1976) 0.89
Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: effect of treatment with protease inhibitors. Rev Infect Dis (1984) 0.88
The female prostate and prostate-specific antigen. Immunohistochemical localization, implications of this prostate marker in women and reasons for using the term "prostate" in the human female. Histol Histopathol (2000) 0.87
Condylomata acuminata: treatment by autogenous vaccine. IMJ Ill Med J (1975) 0.87
Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins. Am J Reprod Immunol Microbiol (1985) 0.87
Immunochemical characterization of epithelial antigen(s) reactive with pemphigus-like antibodies of rabbit and human pemphigus autoantibodies. J Hyg Epidemiol Microbiol Immunol (1969) 0.87
Attachment of an aminoglycoside, amikacin, to implantable collagen for local delivery in wounds. Antimicrob Agents Chemother (1993) 0.86
Cancer, immunological surveillance, and 2 -globulin. Lancet (1972) 0.86
Characterization of Candida isolates from pediatric burn patients. J Clin Microbiol (1988) 0.86
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of anti-tumour cell-mediated immunity and "blocking" factor. Eur J Cancer (1977) 0.85
Circulating levels of tumour necrosis factor, interleukin 6 and proteolytic activity in a murine model of burn and infection. Burns (1996) 0.85
Antigenic components of normal and burned mouse skin. Experientia (1970) 0.84
Lipofuscin granules in normal, benign and malignant human prostatic tissue. Urol Res (1973) 0.84
Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa. Treatment with intravenous immune globulin. Am J Med (1984) 0.84
Then and now: studies using a burned mouse model reflect trends in burn research over the past 25 years. Burns (1999) 0.83
Transglutaminase: co-factor in aetiology of AIDS? Lancet (1985) 0.83
Immunopathologic studies of experimental pemphigus-like autoantibodies and bullous-like lesions. J Invest Dermatol (1969) 0.83
Prostaglandin modulation of prostate tumor growth and metastases. Anticancer Res (1986) 0.82
A retrospective look at studies on prostate-specific antigen. Clin Chem (1985) 0.82
Selection of topical antimicrobial agents for cultured skin for burns by combined assessment of cellular cytotoxicity and antimicrobial activity. Plast Reconstr Surg (1993) 0.82
Biochemical examination of sera during systemic Candida infection in mice. Infect Immun (1978) 0.82
A tissue type transglutaminase in human seminal plasma. Am J Reprod Immunol (1997) 0.82
Immunosuppression of cell- and serum-medicated tumour-associated immunity in prostatic cancer by human seminal plasma. Eur J Cancer (1980) 0.82
Adjuvant immunotherapy (BCG) in stage D prostate cancer. Am J Clin Oncol (1982) 0.82
Comparative evaluation of the Candida agglutinin test, precipitin test, and germ tube dispersion test in the diagnosis of candidiasis. J Clin Microbiol (1976) 0.82
In vivo bound immunoglobulins in the human prostate--their identification and possible significance. Z Immunitatsforsch Exp Klin Immunol (1972) 0.82
Experience with amphotericin-B in the treatment of systmeic candidiasis in burn patients. Am J Surg (1977) 0.81
Antiepithelial antibodies in the serum of patients with benign and malignant diseases of the prostate. Z Immunitatsforsch Exp Klin Immunol (1973) 0.81
Cryosurgery of the rabbit prostate. Comparison of the immune response of immature and mature bucks. Cryobiology (1974) 0.81
Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin's disease. Thromb Haemost (1988) 0.81
Autoallergy in pemphigus. Lancet (1968) 0.81
Fluorescent studies of antibodies to rabbit male urogenital tissue. Experientia (1969) 0.81
Components of the increased circulating proteolytic activity in pediatric burn patients. J Trauma (1992) 0.81
Letter: Antiepithelial antibodies: a possible clue to malignant neoplasms. Arch Dermatol (1974) 0.81
Freezing of the esophagus: histological changes and immunological response. Int Surg (1982) 0.81
Suppression of tumor-associated immunity by human seminal plasma and its possible role in the natural history of prostatic cancer. Eur Urol (1980) 0.80
Carcinoembryonic antigen in the diagnosis of prostate carcinoma. Oncology (1974) 0.80
Absorption studies on antigen(s) of the esophageal mucosa reactive with autoantibodies of pemphigus. Int Arch Allergy Appl Immunol (1968) 0.80
Proteolytic activity and fatal gram-negative sepsis in burned mice: effect of exogenous proteinase inhibition. Infect Immun (1994) 0.80
Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration. Urol Int (1976) 0.79
Modulatory effects of oestrogen on immunological responsiveness. II. Suppression of tumour-associated immunity in patients with prostatic cancer. Clin Exp Immunol (1979) 0.79
Characterization and biological activity of the monocytosis-producing agent of Listeria monocytogenes. J Bacteriol (1969) 0.79
Elution of in vivo bound antiprostatic epithelial antibodies following multiple cryotherapy of carcinoma of prostate. Urology (1973) 0.79
Anti-tissue IgG antibodies and deficiency of IgA. Vox Sang (1972) 0.79
Androgens and oestrogens may modulate the growth and function of lymphoid organs. J Immunol (1984) 0.79
Selective deficiency of IgA. Lancet (1971) 0.79
Modulatory effects of estrogen on immunologic responsiveness. III. Effect of hormonal versus nonhormonal therapy on tumor-associated immunity in prostatic cancer. Am J Reprod Immunol (1981) 0.79
Immunotherapy for prostatic cancer. Previous and prospective considerations. Oncology (1975) 0.79
Effect of a human IgG preparation rich in antibodies to a wide range of lipopolysaccharides on gram-negative bacterial sepsis in burned mice. APMIS (1993) 0.79
Effect of challenge with Candida albicans strains with different levels of virulence on plasma proteins in burned mice. Infect Immun (1991) 0.78
Salmonella typhimurium virulence in a burned-mouse model. Infect Immun (1989) 0.78
Immunosuppressive effect of estrogen on thymic dependent lymphocytic blastogenesis. Urol Res (1974) 0.78